Pain News and Research

Latest Pain News and Research

Pennsylvania physicians examine back-to-school health, offer tips for parents and students

Pennsylvania physicians examine back-to-school health, offer tips for parents and students

Imaging studies required to diagnose traumatic injuries in pregnant women can be safe when used properly

Imaging studies required to diagnose traumatic injuries in pregnant women can be safe when used properly

Report: Florida falling short on policies to prevent, fight cancer

Report: Florida falling short on policies to prevent, fight cancer

Meniscal transplant surgery reduces pain, improves knee function in most patients younger than age 50

Meniscal transplant surgery reduces pain, improves knee function in most patients younger than age 50

Allergan receives FDA approval to market 28 additional styles of Natrelle 410 silicone-filled breast implants

Allergan receives FDA approval to market 28 additional styles of Natrelle 410 silicone-filled breast implants

In vitro testing provides proof of concept for osteopathic manipulative therapy

In vitro testing provides proof of concept for osteopathic manipulative therapy

Non-surgical approach to treating 'double chins'

Non-surgical approach to treating 'double chins'

Coordinated, two-part approach could help reduce hospital-acquired infections

Coordinated, two-part approach could help reduce hospital-acquired infections

Access to dental care by low-income Americans becomes exception as only fewer dentists accept Medicaid

Access to dental care by low-income Americans becomes exception as only fewer dentists accept Medicaid

Halyard Health’s net sales decrease $389 million to 6% in second quarter 2015

Halyard Health’s net sales decrease $389 million to 6% in second quarter 2015

Imperial Innovations announces launch of pre-clinical spinout company, Orthonika

Imperial Innovations announces launch of pre-clinical spinout company, Orthonika

People with chronic insomnia may be able to get relief from half of standard sleeping pills

People with chronic insomnia may be able to get relief from half of standard sleeping pills

Special issue of Ergonomics in Design explores health and safety effects of sedentary workplace

Special issue of Ergonomics in Design explores health and safety effects of sedentary workplace

FAU pre-medical student and surgeon work together on revolutionary procedure alternative to radical mastectomy

FAU pre-medical student and surgeon work together on revolutionary procedure alternative to radical mastectomy

First patient enrolled in Contravir‘s FV-100 Phase 3 study to prevent shingles, shingles-associated pain

First patient enrolled in Contravir‘s FV-100 Phase 3 study to prevent shingles, shingles-associated pain

Shionogi’s naldemedine meets primary, secondary endpoints for treatment of opioid-induced constipation

Shionogi’s naldemedine meets primary, secondary endpoints for treatment of opioid-induced constipation

Array Biopharma reports strong fourth quarter and full year 2015 financial results

Array Biopharma reports strong fourth quarter and full year 2015 financial results

Charleston Laboratories begins Phase 1 study on CL-H1T migraine drug candidate

Charleston Laboratories begins Phase 1 study on CL-H1T migraine drug candidate

Omeros receives EC approval to market Omidria in EU and other European countries

Omeros receives EC approval to market Omidria in EU and other European countries

Sorrento to develop and market monoclonal antibodies for North American, European and Japanese market

Sorrento to develop and market monoclonal antibodies for North American, European and Japanese market

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.